packageEculizumab

eculizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Eculizumab, a monoclonal antibody that inhibits complement, is used to treat conditions such as paroxysmal nocturnal hemoglobinuria, myasthenia gravis, and hemolytic-uremic syndrome. It is authorised in the European Union, where it is used for rare blood and immune-related disorders.

Summary written by glm-5.3-flash from Wikidata Q421617 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:eculizumab
ATC codes:L04AA25, L04AJ01
DrugBank:DB01257
Wikidata:Q421617
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown